Matthews亚洲股利主动型ETF ADVE 深 沪
已收盘 02-06 16:00:00 美东时间
42.9424
+1.115
+2.67%
华盛通- 最 高42.9424
- 今 开42.68
- 成交量 1624股
- 最 低 42.68
- 昨 收 41.8273
- 总市值 644.14万
- 52周最高 42.9424
- 市盈率 静 --
- 换手率 1.08%
- 52周最低 25.9144
- 委 比 0.00%
- 总股本 15.00万
- 历史最高 42.9424
- 量 比 0.55
- 振 幅 0.63%
- 历史最低 25.3216
- 每 手 1
- 风险率 3.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多UPDATE 1-AI fears fuel selloff in software, data and advertising stocks
UPDATE 1-AI fears fuel selloff in software, data and advertising stocks AI threat causes selloff in software and advertising stocks RELX, Wolters Kluwer, Thomson Reuters down over 10% Publicis shares fall 9%, plans AI-focused acquisitions in 2026 Updates prices, adds detail and investor comment By S
02-04 00:37
BRIEF-Pfizer’S Ultra-Long-Acting Injectable Glp-1 RA Shows Weight Loss Results In Phase 2B Trial
BRIEF-Pfizer’S Ultra-Long-Acting Injectable Glp-1 RA Shows Weight Loss Results In Phase 2B Trial Feb 3 (Reuters) - Pfizer Inc PFE.N : PFIZER’S ULTRA-LONG-ACTING INJECTABLE GLP-1 RA SHOWS ROBUST AND CONTINUED WEIGHT LOSS WITH MONTHLY DOSING IN PHASE 2B TRIAL PFIZER’S ULTRA-LONG-ACTING INJECTABLE GLP-
02-03 21:21
AI concerns pummel European software stocks
AI concerns pummel European software stocks AI threat causes selloff in European software and advertising stocks RELX and Wolters Kluwer shares drop over 10% due to AI concerns Publicis shares fall 8.5%, plans AI-focused acquisitions in 2026 By Samuel Indyk and Danilo Masoni LONDON, Feb 3 (Reuters)
02-03 20:29
BRIEF-Electrolux Proposes No Dividend For 2025
BRIEF-Electrolux Proposes No Dividend For 2025 Jan 30 (Reuters) - Electrolux AB ELUXb.ST : Q4 REVENUE SEK 35,112 MILLION Q4 NET INCOME SEK 466 MILLION Q4 ORGANIC GROWTH 2% Q4 EBIT SEK 1,517 MILLION PROPOSES NO DIVIDEND FOR 2025 IN NORTH AMERICA, WE EXPECT MARKET DEMAND TO BE NEUTRAL TO NEGATIVE IN 2
01-30 14:07
BRIEF-Remy Cointreau Confirms 2025-26 Guidance, Sees Currency Effects On Sales, Operating Profit Over FY
BRIEF-Remy Cointreau Confirms 2025-26 Guidance, Sees Currency Effects On Sales, Operating Profit Over FY Jan 29 (Reuters) - Remy Cointreau SA RCOP.PA : Q3 SALES EUR 245.8 MILLION (VERSUS EUR 243.8 MILLION IN COMPANY-PROVIDED CONSENSUS) Q3 ORGANIC GROWTH +2.8% (VERSUS +1.7% IN COMPANY-PROVIDED CONSEN
01-29 14:28
Cook and Powell watch as US Supreme Court debate 'cause' to fire Fed officials
Cook and Powell watch as US Supreme Court debate 'cause' to fire Fed officials Trump seeks to oust Federal Reserve Governor Lisa Cook Fed Chair Powell target of Trump administration probe Court mulls presidential powers related to central bank By David Lawder WASHINGTON, Jan 21 (Reuters) - The two p
01-22 07:26
Five takeaways from the U.S. Supreme Court argument over Fed's Lisa Cook
Five takeaways from the U.S. Supreme Court argument over Fed's Lisa Cook By Jan Wolfe Jan 21 (Reuters) - The U.S. Supreme Court heard arguments on Wednesday over President Donald Trump 's attempt to fire Federal Reserve Governor Lisa Cook. Here are some takeaways from the arguments in the case, a cr
01-22 03:32
BRIEF-FDA Takes Steps To Improve Gluten Ingredient Disclosure In Foods
BRIEF-FDA Takes Steps To Improve Gluten Ingredient Disclosure In Foods Jan 21 (Reuters) - FDA: FDA TAKES STEPS TO IMPROVE GLUTEN INGREDIENT DISCLOSURE IN FOODS FDA: AGENCY IS SEEKING INFORMATION ON ADVERSE REACTIONS DUE TO “INGREDIENTS OF INTEREST” US FDA - ISSUES RFI ON LABELING & PREVENTING CROSS-
01-21 23:09
BRIEF-OpenAI Has Started Offering Its New Chatbot Ads To Dozens Of Advertisers - The Information
BRIEF-OpenAI Has Started Offering Its New Chatbot Ads To Dozens Of Advertisers - The Information Jan 20 (Reuters) - OPENAI HAS STARTED OFFERING ITS NEW CHATBOT ADS TO DOZENS OF ADVERTISERS- THE INFORMATION OPENAI TO LAUNCH CHATBOT ADS IN FEBRUARY, CHARGING BASED ON AD VIEWS - THE INFORMATION Source
01-21 11:33
BRIEF-Traws Pharma Announces Completion Of Phase I Studies With Tivoxavir Marboxil
Jan 23 (Reuters) - Traws Pharma Inc TRAW.O: TRAWS PHARMA ANNOUNCES COMPLETION OF PHASE I STUDIES WITH TIVOXAVIR MARBOXIL, A SINGLE DOSE ORAL INVESTIGATIONAL DRUG FOR THE TREATMENT AND PREVENTION OF H5...
2025-01-23 20:14
